Editorial: The Golden Future in Medicinal Chemistry: Perspectives and Resources From Old and New Gold-Based Drug Candidates

Lara Massai; Sanja Grguric-Sipka; Wukun Liu; Benoît Bertrand; Alessandro Pratesi

doi:10.3389/fchem.2021.665244

Editorial: The Golden Future in Medicinal Chemistry: Perspectives and Resources From Old and New Gold-Based Drug Candidates

Front Chem. 2021 Mar 18:9:665244. doi: 10.3389/fchem.2021.665244. eCollection 2021.

Authors

Lara Massai¹, Sanja Grguric-Sipka², Wukun Liu³, Benoît Bertrand⁴, Alessandro Pratesi⁵

Affiliations

¹ Laboratory of Metals in Medicine (MetMed), Department of Chemistry "U. Schiff", University of Florence, Florence, Italy.
² Faculty of Chemistry, University of Belgrade, Belgrade, Serbia.
³ School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
⁴ Sorbonne Université, CNRS, Institut Parisien de Chimie Moléculaire (IPCM), Paris, France.
⁵ Department of Chemistry and Industrial Chemistry (DCCI), University of Pisa, Pisa, Italy.

No abstract available

Keywords: anticancer compounds; anticancer immunity; dihydrofolate reductase; enzyme inhibition; gold complexes; mass spectrometry; mode-of-action; protein metalation.

Publication types

Editorial